The silencing of the L1-MET chimeric transcript activates cancer cell death program and inhibits the expression of crucial oncoproteins in lung cancer cells
Preprint in Research Square (August 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain
Article in JCI Insight (May 2023)
Tool and Techniques on Computer-Aided Drug Design for Targeted Cancer Therapy
Book chapter (April 2023)